19:50 EDT Passage Bio (PASG) trading halted, news pending
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PASG:
- Passage Bio announces 1-for-20 reverse stock split
- Optimistic Buy Rating for Passage Bio’s PBFT02: Promising Efficacy and Managed Safety Concerns
- Passage Bio’s Promising Clinical Trial Results and Strategic Adjustments Justify Buy Rating
- Passage Bio Releases Promising Interim Data for PBFT02
- Passage Bio reports updated interim data from upliFT-D study of PBFT02